Structure-activity relationships of alpha-conotoxins targeting neuronal nicotinic acetylcholine receptors.

alpha-Conotoxins that target the neuronal nicotinic acetylcholine receptor have a range of potential therapeutic applications and are valuable probes for examining receptor subtype selectivity. The three-dimensional structures of about half of the known neuronal specific alpha-conotoxins have now been determined and have a consensus fold containing a helical region braced by two conserved disulfide bonds. These disulfide bonds define the two-loop framework characteristic for alpha-conotoxins, CCXmCXnC, where loop 1 comprises four residues (m = 4) and loop 2 between three and seven residues (n = 3, 6 or 7). Structural studies, particularly using NMR spectroscopy have provided an insight into the role and spatial location of residues implicated in receptor binding and biological activity.

[1]  F. Castellino,et al.  Direct binding properties of conantokins to native N-methyl-d-aspartate receptors. , 2003, The journal of peptide research : official journal of the American Peptide Society.

[2]  A. Arseniev,et al.  NMR spatial structure of α‐conotoxin ImI reveals a common scaffold in snail and snake toxins recognizing neuronal nicotinic acetylcholine receptors 1 , 1999, FEBS letters.

[3]  Leu10 of α-conotoxin PnIB confers potency for neuronal nicotinic responses in bovine chromaffin cells , 2000 .

[4]  J. Changeux,et al.  Functional determinants by which snake and cone snail toxins block the α7 neuronal nicotinic acetylcholine receptors , 1998, Journal of Physiology-Paris.

[5]  D. Yoshikami,et al.  α-Conotoxin AuIB Selectively Blocks α3β4 Nicotinic Acetylcholine Receptors and Nicotine-Evoked Norepinephrine Release , 1998, The Journal of Neuroscience.

[6]  A. Arseniev,et al.  Two distinct structures of alpha-conotoxin GI in aqueous solution. , 1998, European journal of biochemistry.

[7]  R. Stevens,et al.  NMR solution structure of alpha-conotoxin ImI and comparison to other conotoxins specific for neuronal nicotinic acetylcholine receptors. , 1999, Biochemistry.

[8]  D. Groebe,et al.  alpha-Conotoxin EI, a new nicotinic acetylcholine receptor antagonist with novel selectivity. , 1995, Biochemistry.

[9]  J. McIntosh,et al.  α-Conotoxins ImI and ImII , 2003, The Journal of Biological Chemistry.

[10]  J. McIntosh,et al.  Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes. , 1999, Annual review of biochemistry.

[11]  Jon M. Lindstrom,et al.  α-Conotoxin PIA Is Selective for α6 Subunit-Containing Nicotinic Acetylcholine Receptors , 2003, The Journal of Neuroscience.

[12]  Carol L. Williams,et al.  Nicotinic Acetylcholine Receptors of Muscle and Neuronal (α7) Types Coexpressed in a Small Cell Lung Carcinoma , 1997 .

[13]  F. Castellino,et al.  Kinetic and mechanistic characterization of NMDA receptor antagonism by replacement and truncation variants of the conantokin peptides , 2001, Neuropharmacology.

[14]  M. O'Neill,et al.  The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration. , 2002, Current drug targets. CNS and neurological disorders.

[15]  J. Haack,et al.  Conantokin-T. A gamma-carboxyglutamate containing peptide with N-methyl-d-aspartate antagonist activity. , 1990, The Journal of biological chemistry.

[16]  D. Craik,et al.  Solution structure of alpha-conotoxin ImI by 1H nuclear magnetic resonance. , 1999, Journal of medicinal chemistry.

[17]  David John Adams,et al.  α-Conotoxin EpI, a Novel Sulfated Peptide from Conus episcopatus That Selectively Targets Neuronal Nicotinic Acetylcholine Receptors* , 1998, The Journal of Biological Chemistry.

[18]  D. Craik,et al.  The 1.1 A crystal structure of the neuronal acetylcholine receptor antagonist, alpha-conotoxin PnIA from Conus pennaceus. , 1996, Structure.

[19]  D. Yoshikami,et al.  α-Conotoxin GIC from Conus geographus, a Novel Peptide Antagonist of Nicotinic Acetylcholine Receptors* , 2002, The Journal of Biological Chemistry.

[20]  D. Craik,et al.  alpha-Conotoxins: nicotinic acetylcholine receptor antagonists as pharmacological tools and potential drug leads. , 2001, Current medicinal chemistry.

[21]  J. Rivier,et al.  Three-Dimensional Solution Structure of α-Conotoxin MII, an α3β2 Neuronal Nicotinic Acetylcholine Receptor-Targeted Ligand†,‡ , 1997 .

[22]  F. Castellino,et al.  The Amino Acid Residue at Sequence Position 5 in the Conantokin Peptides Partially Governs Subunit-selective Antagonism of RecombinantN-Methyl-d-aspartate Receptors* , 2001, The Journal of Biological Chemistry.

[23]  R. Lewis,et al.  Alpha-conotoxins as tools for the elucidation of structure and function of neuronal nicotinic acetylcholine receptor subtypes. , 2004, European journal of biochemistry.

[24]  C M Weeks,et al.  The 1.1 A resolution crystal structure of [Tyr15]EpI, a novel alpha-conotoxin from Conus episcopatus, solved by direct methods. , 1998, Biochemistry.

[25]  D. Craik,et al.  Determination of the Solution Structures of Conantokin-G and Conantokin-T by CD and NMR Spectroscopy* , 1997, The Journal of Biological Chemistry.

[26]  D. Craik,et al.  Structure-activity studies of conantokins as human N-methyl-D-aspartate receptor modulators. , 1999, Journal of medicinal chemistry.

[27]  Kyou-Hoon Han,et al.  Nuclear Magnetic Resonance Solution Conformation of α-Conotoxin AuIB, an α3β4 Subtype-selective Neuronal Nicotinic Acetylcholine Receptor Antagonist* , 2000, The Journal of Biological Chemistry.

[28]  S. Sine,et al.  Molecular dissection of subunit interfaces in the nicotinic acetylcholine receptor , 1998, Journal of Physiology-Paris.

[29]  O. Steinlein.  Nicotinic acetylcholine receptors and epilepsy. , 2002, Current drug targets. CNS and neurological disorders.

[30]  W R Gray,et al.  Three-dimensional structure of the alpha-conotoxin GI at 1.2 A resolution. , 1996, Biochemistry.

[31]  D. Bertrand,et al.  α-Conotoxins PnIA and [A10L]PnIA Stabilize Different States of the α7-L247T Nicotinic Acetylcholine Receptor* , 2003, Journal of Biological Chemistry.

[32]  D. Craik,et al.  Crystal structure at 1.1 A resolution of alpha-conotoxin PnIB: comparison with alpha-conotoxins PnIA and GI. , 1997, Biochemistry.

[33]  P. Lyu,et al.  Calcium binding mode of γ-carboxyglutamic acids in conantokins , 1999 .

[34]  D. Craik,et al.  Single Amino Acid Substitutions in α-Conotoxin PnIA Shift Selectivity for Subtypes of the Mammalian Neuronal Nicotinic Acetylcholine Receptor* , 1999, The Journal of Biological Chemistry.

[35]  D. Yoshikami,et al.  A New -Conotoxin Which Targets 32 Nicotinic Acetylcholine Receptors (*) , 1996, The Journal of Biological Chemistry.

[36]  S. Sine,et al.  Structural Elements in α-Conotoxin ImI Essential for Binding to Neuronal α7 Receptors* , 1998, The Journal of Biological Chemistry.

[37]  Y. Utkin,et al.  Aromatic substitutions in α-conotoxin ImI. , 1999 .

[38]  H. Geerts,et al.  Nicotinic receptor modulation: advantages for successful Alzheimer's disease therapy. , 2002, Journal of neural transmission. Supplementum.

[39]  D. Craik,et al.  Structure determination of the three disulfide bond isomers of alpha-conotoxin GI: a model for the role of disulfide bonds in structural stability. , 1998, Journal of molecular biology.

[40]  D. Craik,et al.  A New Level of Conotoxin Diversity, a Non-native Disulfide Bond Connectivity in α-Conotoxin AuIB Reduces Structural Definition but Increases Biological Activity* , 2002, The Journal of Biological Chemistry.

[41]  David John Adams,et al.  Chemical and functional identification and characterization of novel sulfated alpha-conotoxins from the cone snail Conus anemone. , 2004, Journal of medicinal chemistry.

[42]  S. Sine,et al.  Pairwise Interactions between Neuronal α7Acetylcholine Receptors and α-Conotoxin PnIB* , 2000, The Journal of Biological Chemistry.

[43]  D. Keays,et al.  A novel alpha-conotoxin identified by gene sequencing is active in suppressing the vascular response to selective stimulation of sensory nerves in vivo. , 2003, Biochemistry.

[44]  E. Sher,et al.  α-Conotoxin imperialis I inhibits nicotine-evoked hormone release and cell proliferation in human neuroendocrine carcinoma cells , 1996, Neuroscience Letters.

[45]  D. Yoshikami,et al.  Single-Residue Alteration in α-Conotoxin PnIA Switches Its nAChR Subtype Selectivity† , 1999 .

[46]  A. Ménez,et al.  Minimal conformation of the ±‐conotoxin ImI for the ±7 neuronal nicotinic acetylcholine receptor recognition: correlated CD, NMR and binding studies , 1999, FEBS letters.

[47]  S. Sine,et al.  Identification of Residues in the Neuronal α7Acetylcholine Receptor That Confer Selectivity for Conotoxin ImI* , 1998, The Journal of Biological Chemistry.

[48]  S. Hirono,et al.  Solution structure of α-conotoxin ImI determined by two-dimensional NMR spectroscopy , 1999 .

[49]  P. Alewood,et al.  Physico-chemical characterization and synthesis of neuronally active alpha-conotoxins. , 2004, European journal of biochemistry.

[50]  Sébastien Dutertre,et al.  Computational approaches to understand alpha-conotoxin interactions at neuronal nicotinic receptors. , 2004, European journal of biochemistry.

[51]  D. Craik,et al.  Three-dimensional solution structure of alpha-conotoxin MII by NMR spectroscopy: effects of solution environment on helicity. , 1998, Biochemistry.

[52]  D. Craik,et al.  Synthesis, structure elucidation, in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic analogues of alpha-conotoxin MII. , 2003, Journal of medicinal chemistry.

[53]  R. Stevens,et al.  Structure-activity relationships in a peptidic alpha7 nicotinic acetylcholine receptor antagonist. , 2000, Journal of molecular biology.

[54]  D. Craik,et al.  Isolation, Structure, and Activity of GID, a Novel α4/7-Conotoxin with an Extended N-terminal Sequence* , 2003, The Journal of Biological Chemistry.